investingreview.org logo
Obtenez les faits, trouvez le meilleur et évitez la fraude
Nothings Found.

Analyzing Capital Guardian Trust Co's Q1 and Q2 2019 Holdings: Winners, Losers, and Surprises

Ava Hoppe | 23 April, 2023

Capital Guardian Trust Co, a subsidiary of Capital Group, is one of the most renowned investment management firms in the world. They recently released their 13-F filings for the first and second quarters of 2019, revealing changes in their holdings for that period. In this blog post, we’ll dive into the data and analyze which stocks they added to, reduced, or completely exited from their portfolio, as well as highlight some surprising trends that emerged from their Q1-Q2 movements.

First, let’s take a look at the ten highest valued holdings in Q2 2019 for Capital Guardian Trust Co:

* ENBRIDGE INC (ENB.TO)

* TAIWAN SEMICONDUCTOR MFG CO ADR (TSM)

* MICROSOFT CORP (MSFT)

* VISA INC CL A (V)

* HDFC BANK LTD ADR (HDB)

* FACEBOOK INC CL A (META)

* BROADCOM INC (AVGO)

* VALE SA ON ADR (VALE)

* CHARTER COMMUNICATIONS INC CL A (CHTR)

* AON PLC CL A (AON)

Some interesting changes in Capital Guardian's top holdings for Q1 2019 include the reduction of Vale SA ON ADR from almost 10 million shares to just over 8.5 million, marking an 8.2% decrease in value. However, Vale wasn't the only position that experienced a sizeable dip. Ctrip.com Intl ADR (TCOM) saw a whopping 45.1% decline in shares held, while Amazon.com Inc (AMZN) slid down by 4.5%.

On the other hand, two stocks that saw significant increases in shares held by Capital Guardian were Taiwan Semiconductor Mfg Co ADR, which saw an 8.8% increase in shares held, and Facebook Inc CL A, which increased by 16.7%. Other noticeable gains were Equinix Inc (EQIX) which rose by nearly 30%, Comcast Corp CL A (CMCSA) by 51%, and ABBOTT LABORATORIES (ABT) by 233.2%.

Another noteworthy change was the complete exit of two positions from the portfolio- Biohaven Pharmaceutical Holding Co Ltd and America Movil SAB de CV L ADR. Meanwhile, SAP SE ADR and AstraZeneca PLC ADR were introduced as new positions in Q2 2019.

Looking at the bigger picture, the Q1 to Q2 movements from Capital Guardian show less drastic changes compared to other institutional investors who have recently reported their 13-F filings. This indicates that Capital Guardian is confident in the long-term growth prospects of their portfolio stocks with only minor adjustments being made over the first half of 2019.

In conclusion, while there were a few notable drops in holdings, Capital Guardian Trust Co continued to show faith in most of their core holdings with minimal changes being made. It will be interesting to follow up on their Q3 and Q4 reports to see if there are any significant shifts in their portfolio or if they continue to maintain their strategy of stability and growth.

De nombreuses personnes ont été brûlées par des fraudes et des stratagèmes de Ponzi. Nous avons donc créé ce site Web pour vous aider, en tant qu’investisseur potentiel, à obtenir les faits, à trouver le meilleur des moyens, et à éviter la fraude et les stratagèmes de Ponzi.

Toutes les informations fournies sur ce site sont fournies sans garantie et à des fins d'information uniquement.
InvestingReview.org ne fournit pas de conseils en investissement. InvestingReview.org n'est pas un conseiller en investissement et n'est ni endossé ni affilié à un organisme de réglementation américain ou non américain.


Entreprises récemment recherchées

Remarque: les données de recherche sont accumulées par des tiers et actualisées une fois par jour.

Copyright © 2023 by InvestingReview.org / Tous droits réservés.